Veru Inc works with GT-024 and Veru-111
The University Of Tennessee Health Science CenterHigher Ed · Memphis, TN- Document date
- Apr 8, 2025
The 30-second brief
Veru Inc. is working with UT Health Science Center with GT-024(Enobosarm) to preserve muscle in GLP-1 patients. Veru-111(Sabizabulin) is being tested for Anti-viral: ARDS in COVID-19; general
VERU holds this pharmaceuticals contract with The University Of Tennessee Health Science Center.
See every contract and contact at The University Of Tennessee Health Science Center.
See every contractFree account · 30-second setup · No credit card
Contract details
- Contract type
- Pharmaceuticals
- Document date
- April 8, 2025
- Term
- NA
- Vendor
- VERU
- Source document
- the-university-of-tennessee-health-science-center-meeting-minutes-2025-04-08_2d2.pdf (Meeting Minutes)
More The University Of Tennessee Health Science Center contracts
Questions about this contract
Who was awarded the pharmaceuticals contract by The University Of Tennessee Health Science Center?
VERU was awarded this pharmaceuticals contract by The University Of Tennessee Health Science Center, as recorded on April 8, 2025.
What type of contract is this?
This is a Pharmaceuticals contract, documented as a meeting minutes record.
Where was this contract approved?
This contract appears in the-university-of-tennessee-health-science-center-meeting-minutes-2025-04-08_2d2.pdf (Meeting Minutes), dated April 8, 2025 from The University Of Tennessee Health Science Center. Civic IQ extracts contract records directly from agency meeting documents and solicitations.
What other contracts does VERU hold?
VERU may hold additional government contracts. View their full contract history, the agencies they serve, and total tracked spend on their Civic IQ vendor profile.
Show 1 more question
What is The University Of Tennessee Health Science Center currently buying?
Explore The University Of Tennessee Health Science Center's vendors, signed contracts, and active RFPs on their Civic IQ agency profile.